- Research works
- 13 ▲ 17% vs 2018-21
- Citations
- 292 23.3 per fractional work
- Top-10% rate
- 7.0% all institutions 10.0%
- Open access
- 39% world 40%
- International
- 12% world 18%
Not ranked overall: Chrono Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Chrono Therapeutics (United States) work in?
In all years, 65% of research at Chrono Therapeutics (United States) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (56%), Medicine (27%), Immunology and Microbiology (7%). It does 2.3× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 9 fields, with their numbers
- Life Sciences865.4%
- Health Sciences327.5%
- Medicine327.4%
- Veterinary00.1%
- Physical Sciences16.9%
- Chemistry14.5%
- Materials Science02.0%
- Engineering00.4%
- Social Sciences00.2%
- Psychology00.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Chrono Therapeutics (United States) publish most on?
By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Advanced Biosensing Techniques and Applications and Click Chemistry and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 2 HER2/EGFR in Cancer Research Oncology 1 works
- 3 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
- 4 Click Chemistry and Applications Organic Chemistry 0 works
- 5 Immunotherapy and Immune Responses Immunology 0 works
- 6 Immune Cell Function and Interaction Immunology 0 works
- 7 Single-cell and spatial transcriptomics Molecular Biology 0 works
- 8 Genomics and Chromatin Dynamics Molecular Biology 0 works
- 9 Advanced Fluorescence Microscopy Techniques Biophysics 0 works
- 10 interferon and immune responses Immunology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Chrono Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 17% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Chrono Therapeutics (United States) as a percentage of every work published that year, 0.0000072% in 2024.
Fractional works of Chrono Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Hayward
- California State University, East Bay
- Biolog (United States)
- X-ray Instrumentation Associates (United States)
- Planet Biotechnology (United States)
- Advanced Cell Diagnostics (United States)
- Sepragen Corporation (United States)
- Abeam Technologies (United States)
- RefleXion Medical (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Chrono Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.